Drugmaker AstraZeneca recently settled a lawsuit with the state of Kentucky over allegations of improperly marketing its atypical antipsychotic drug Seroquel. Under the settlement, the London-based pharmaceutical company will pay the Bluegrass State $5.5 million.
The former director of nursing at a California nursing home was sentenced Wednesday to three years in prison for administering powerful drugs to subdue residents.
May 29, 2012
The U.S. Senate did not approve legislation that would strengthen regulations for antipsychotic use in nursing homes, despite overwhelmingly passing a bill it was attached to on Thursday.
May 01, 2012
While antipsychotic drug use overuse has decreased since 2005, nearly a quarter of U.S. nursing homes are still giving many residents the medications against recommendations, a Boston Globe analysis reveals.
Government prosecutors rejected a proposed settlement worth roughly $1 billion with pharmaceutical giant Johnson & Johnson over questionable marketing tactics for the antipsychotic Risperdal.
The Senate Special Committee on Aging will hold a hearing today about the use of antipsychotics in nursing homes.The hearing, titled "Overprescribed: The Human and Taxpayers' Costs of Antipsychotics in Nursing Homes," will be at 2 pm ET.
Pharmaceutical giant AstraZeneca has agreed to pay $520 million to end a federal investigation into its alleged illegal marketing of the drug Seroquel for off-label uses, according to reports from Washington.
January 19, 2010
The U.S. Department of Justice on Friday filed a lawsuit against Johnson & Johnson for its alleged role in a kickback scheme with Omnicare, the nation's largest long-term care pharmacy chain.
